
Explore complete financial details, shareholding patterns, and trade unlisted shares securely.
Current Offer Price
S3V Vascular Technologies Limited, founded in 2011 and headquartered in Mysore, Karnataka, is a medical device manufacturer focused on advanced cardiovascular and critical-care products, operating through a fully integrated model that combines in-house research and development, proprietary technology and regulated manufacturing facilities. It became the first company to receive a manufacturing license for an expandable titanium-based intervertebral body fusion device (expandable spinal cage), with the first successful implant performed in Pune, and is currently the only manufacturer globally offering this specific expandable cage. Its product portfolio includes drug-eluting and bare-metal stents, PTCA and neurovascular catheters, esophageal and biliary stents, and India’s first indigenous mechanical thrombectomy device for stroke treatment, aiming to reduce import dependence and improve affordability in a market largely dominated by imported devices. Led by promoter Badari Narayan, a m...
| S3V Vascular Technologies Limited Price | ₹565.00 Per Equity Share |
| Lot Size | 500 Shares |
| 52 Week High | 565 Shares |
| 52 Week Low | 350 Shares |
| Depository | NSDL & CDSL |
| PAN Number | AAQCS2303F |
| ISIN Number | INE0HGT01012 |
| CIN | U33112KA2011PLC059915 |
| RTA | Aarthi Consultants |
| Market Cap (in Cr.) | 1095.00 |
| P/E Ratio | 18833.33 |
| P/B Ratio | 7.25 |
| D/E Ratio | 0.13 |
| ROE | 0.04 |
| Book Value | 77.97 |
| Face Value | 10.00 |
| Total Shares | 19387980 |
| Field | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| da | 1.5 | 1.7 | 2.07 | 1.4 |
| eps | 2.08 | 0.42 | -1.66 | 0.03 |
| npm | 12.86 | 2.95 | -21.27 | 0.44 |
| opm | 27.62 | 19.47 | 16.67 | -4.22 |
| pat | 2.7 | 0.56 | -3.19 | 0.06 |
| pbt | 2.8 | 0.65 | -3.06 | 0.15 |
| tax | 0.1 | 0.09 | 0.13 | 0.09 |
| ebit | 4.3 | 2 | 0.43 | -1.97 |
| ebitda | 5.8 | 3.7 | 2.5 | -0.57 |
| revenue | 21 | 19 | 15 | 13.5 |
| pbt margins | 13.33 | 3.42 | -20.4 | 1.11 |
| ebit margins | 20.48 | 10.53 | 2.87 | -14.59 |
| finance cost | 1.4 | 1.3 | 3.5 | 1.1 |
| other income | 0.09 | 0.08 | 0.2 | 3.2 |
| gross margins | 63.33 | 58.42 | 63.33 | 74.81 |
| other expenses | 5.5 | 4.8 | 4 | 5.97 |
| change in inventory | 1.1 | -0.6 | 0.8 | -6.9 |
| cost of material consumed | 6.6 | 8.5 | 4.7 | 10.3 |
| employee benefit expenses | 2 | 2.6 | 3 | 4.7 |